FOCIS Centre of Excellence


FOCIS exists to improve human health through immunology by fostering interdisciplinary approaches to both understand and treat immune-based diseases.

The federation was initially established as a cross-disciplinary meeting, and FOCIS held its first Annual Meeting in 2001. FOCIS has more than 50 Member Societies, representing roughly 60,000 clinician scientists. A Federation of this size provides a voice for clinical immunologists and ultimately strives to improve patient care.

FOCIS centre of excellence (FCE)

The FCE status provides an opportunity for CIR to strengthen translational immunology activities and to build an interdisciplinary translational immunology community at our institution. Being a member of the FCE community offers an effective training environment for translational researchers and clinicians by promoting interdisciplinary innovation in research and clinical practices, and promoting new links for researchers and clinicians.

Meetings and training courses

The FCE provides interdisciplinary training programs for students, fellows and continuing education of physicians through FOCIS assisted opportunities.

The annual FOCIS meeting highlights the best science in the field of clinical immunology. In addition, the FOCIS meeting is an incubator for developing scientists and practitioners alike to meet with one another and representatives of the relevant biotech and pharmaceutical industry whose combined support is invaluable to the success of the field of clinical immunology.

CIR will partly cover expences for participating at FOCIS meetings and training courses for CIR-members or clinicians collaborating with CIR. An application must be sent to CIR's Administrative Coordinator.

European network

As a European FCE, CIR has been invited to participate in the European Cooperation in Science and Technology (COST) action "European Network for Translational Immunology Research and Education (ENTIRE): From Immunomonitoring to Personalized Immunotherapy".

FCE Strategy

FOCIS strategy is to establish a variety of diverse of FCEs that are fully functional as interdisciplinary "umbrella" programs that bring a unique approach to research and patient care.

  • Establish a minimal set of FCE requirements
  • Define reciprocal value between FOCIS and FCEs
  • Maintain collaborative relations with NIH-supported centers and institutional centers
  • Create a network for enabling collaborative research and clinical care
  • Evaluate leadership at FCEs to ensure a champion at FCE
  • Create a forum to share expertise on the implementation of emerging technologies
  • Establish local endowments for education and training in clinical research
  • Build on and communicate successes

CIR FCE boards

Lay Advisory Board

The Lay Advisory Board focuses on strategic development, fundraising and community outreach and consists of:

Clinical Advisory Board

The Clinical Advisory Board is responsible for facilitating translational research at CIR. The board consists of:

  • Head physician Knut E. Lundin (chairman, gastroenterologist)
  • Professor II Geir E. Tjønnfjord (hematologist)
  • Professor Knut Dahl-Jørgensen (pediatrician)
Published Feb. 10, 2012 12:13 PM - Last modified Oct. 27, 2015 12:04 PM